Theralase Technologies Inc (TLTFF)

[123414]

Perhaps now is the time for accumulation.

Before big money moves in.

Patient 4 got the full treatment. Missed the 180 mark. Researchers and the company dialed in for 5 and 6. Then 5 and 6 results were very good on the safety trial!

No Clinical Evidence of NMIBC at 180 Day Cystoscopy Analysis

https://app.quotemedia.com/quotetools/newsStoryPopup.go?storyId=5906816113363677&topic=TLTFF&symbology=null&cp=null&webmasterId=90338

This tiny company keeps knocking it out of the park while folks really aren't even looking.

The market pays big for very promising cancer treatments. As we seen in August of 2017.

Theralase has stellar results!

TLTFF long

Cheers!